| ICD Code | Description |
|---|---|
| C220 | Liver cell carcinoma |
| C221 | Intrahepatic bile duct carcinoma |
| C222 | Hepatoblastoma |
| C223 | Angiosarcoma of liver |
| C224 | Other sarcomas of liver |
| C227 | Other specified carcinomas of liver |
| C228 | Malignant neoplasm of liver, primary, unspecified as to type |
| C229 | Malignant neoplasm of liver, not specified as primary or secondary |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C220 | Liver cell carcinoma | 15.48 | |||||||||||||
| C221 | Intrahepatic bile duct carcinoma | 18.1 | |||||||||||||
| C228 | Malignant neoplasm of liver, primary, unspecified as to type | 17.76 | |||||||||||||
| C229 | Malignant neoplasm of liver, not specified as primary or secondary | 20.19 | |||||||||||||
| C227 | Other specified carcinomas of liver | 17.91 | |||||||||||||
| C224 | Other sarcomas of liver | 27.27 | |||||||||||||
| C223 | Angiosarcoma of liver | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C220 | Liver cell carcinoma | 6.01 | 29.18 | ||||||||||||||||
| C221 | Intrahepatic bile duct carcinoma | 6.3 | 31.42 | ||||||||||||||||
| C228 | Malignant neoplasm of liver, primary, unspecified as to type | 5.35 | 27.71 | ||||||||||||||||
| C229 | Malignant neoplasm of liver, not specified as primary or secondary | 5.3 | 28.1 | ||||||||||||||||
| C227 | Other specified carcinomas of liver | 6.03 | 28.37 | ||||||||||||||||
| C223 | Angiosarcoma of liver | 6.54 | 33.77 | ||||||||||||||||
| C224 | Other sarcomas of liver | 7.45 | 31.19 | ||||||||||||||||
| C222 | Hepatoblastoma | 8.84 | 55.77 |